Cyclacel Pharmaceuticals, Inc. (CYCC) Stock Price, News, Quote & History

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},f=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(f(),setInterval((function(){f()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var m=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(eo=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===m&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Gt)),notifLabel:document.querySelector(".".concat(Wt))};to(e,n)}))}()}};

NasdaqCM - Delayed Quote • USD

Compare

1.7500 +0.1000 (+6.06%)

At close: June 21 at 4:00 PM EDT

Key Events

Line

Candle

Baseline

Mountain

Bar

Advanced Chart

Loading Chart for CYCC

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume

Previous Close 1.6500
Open 1.6300
Bid 1.7200 x 100
Ask 1.7900 x 100
Day's Range 1.6217 - 1.8299
52 Week Range 1.3000 - 13.2000
Volume 232,813
Avg. Volume 877,079
Market Cap (intraday) 2.561M
Beta (5Y Monthly) 0.59
PE Ratio (TTM) --
EPS (TTM) -22.0200
Earnings Date Aug 7, 2024 - Aug 12, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 11.00

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors and hematological malignancies, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors and hematological malignancies. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey.

www.cyclacel.com

Full Time Employees

December 31

Recent News: CYCC

All SEC Filings

Corporate Changes & Voting Matters

Periodic Financial Reports

Proxy Statements

Tender Offer/Acquisition Reports

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

CYCC

Cyclacel Pharmaceuticals, Inc.

1.7500

+6.06%

Mkt Cap 2.561M

Industry Biotechnology

BCDA

BioCardia, Inc.

3.0000

-11.24%

Mkt Cap 5.477M

Industry Biotechnology

INM

InMed Pharmaceuticals Inc.

0.2540

+6.72%

Mkt Cap 2.123M

Industry Biotechnology

ALLR

Allarity Therapeutics, Inc.

0.4455

-2.00%

Mkt Cap 7.844M

Industry Biotechnology

ATNF

180 Life Sciences Corp.

1.4600

-11.52%

Mkt Cap 1.375M

Industry Biotechnology

CERO

CERo Therapeutics Holdings, Inc.

0.3452

+19.03%

Mkt Cap 5.2M

Industry Biotechnology

NBY

NovaBay Pharmaceuticals, Inc.

2.1400

-6.14%

Mkt Cap 2.465M

Industry Biotechnology

CDIO

Cardio Diagnostics Holdings, Inc.

0.6000

+20.65%

Mkt Cap 13.611M

Industry Biotechnology

GRI

GRI Bio, Inc.

2.6600

+5.98%

Mkt Cap 1.352M

Industry Biotechnology

PBM

Psyence Biomedical Ltd.

0.3900

-34.44%

Mkt Cap 5.222M

Industry Biotechnology

ZVSA

ZyVersa Therapeutics, Inc.

4.0200

-17.45%

Mkt Cap 3.356M

Industry Biotechnology

Statistics: CYCC

Valuation Measures

As of 4/4/2024

Market Cap

2.56M
Enterprise Value

-216.30k
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

3.77
Price/Book (mrq)

4.60
Enterprise Value/Revenue

-1.08
Enterprise Value/EBITDA

0.02

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-99.60%
Return on Equity (ttm)

-496.02%
Revenue (ttm)

449k
Net Income Avi to Common (ttm)

-19.85M
Diluted EPS (ttm)

-22.0200

Balance Sheet and Cash Flow

Total Cash (mrq)

2.8M
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

-6.24M

Research Analysis: CYCC

People Also Watch

ABIO ARCA biopharma, Inc.

3.5000

+7.36%

AEZS Aeterna Zentaris Inc.

4.5872

+1.04%

BLPH Bellerophon Therapeutics, Inc.

0.0571

-8.64%

CAPR Capricor Therapeutics, Inc.

4.7000

-1.26%

CLRB Cellectar Biosciences, Inc.

2.8600

+2.14%

BNTC Benitec Biopharma Inc.

6.88

+4.24%

MBRX Moleculin Biotech, Inc.

3.7400

-1.06%

CRIS Curis, Inc.

7.96

0.00%

PULM Pulmatrix, Inc.

1.9800

+5.32%

EVOK Evoke Pharma, Inc.

0.6100

+15.31%

AKTX Akari Therapeutics, Plc

3.7100

+20.06%

SNGX Soligenix, Inc.

3.4600

-9.42%

TCON TRACON Pharmaceuticals, Inc.

1.2500

+1.63%

BIOC Biocept, Inc.

0.4349

0.00%

APVO Aptevo Therapeutics Inc.

0.5319

-1.50%

TENX Tenax Therapeutics, Inc.

2.7700

-9.77%

Cyclacel Pharmaceuticals, Inc. (CYCC) Stock Price, News, Quote & History - Yahoo Finance (2024)

Full Time Employees

Fiscal Year Ends

Sector

Industry

Profitability and Income Statement

Balance Sheet and Cash Flow